This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Valeo Pharma Balance Sheet Health

Financial Health criteria checks 0/6

Valeo Pharma has a total shareholder equity of CA$-63.0M and total debt of CA$69.4M, which brings its debt-to-equity ratio to -110.1%. Its total assets and total liabilities are CA$32.2M and CA$95.2M respectively.

Key information

-110.1%

Debt to equity ratio

CA$69.38m

Debt

Interest coverage ration/a
CashCA$7.13m
Equity-CA$63.03m
Total liabilitiesCA$95.23m
Total assetsCA$32.20m

Recent financial health updates

No updates

Recent updates

Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Jun 14
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Apr 20
Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Mar 02
Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Jan 17
Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Jun 08
Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Jun 24
Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 17
Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Feb 08
Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Financial Position Analysis

Short Term Liabilities: VPH has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: VPH has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: VPH has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: VPH's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VPH has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: VPH has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.6% each year


Discover healthy companies